Iman El-Hariry is Chief Medical Officer at ERYTech Pharma SA and Chief Medical Officer for Erytech, Inc. (a subsidiary of ERYTech Pharma SA).

She previously occupied the position of President at Azure Oncology Consulting LLC, Global Head-Oncology at Astellas Pharma, Inc., Vice President-Clinical Research at Synta Pharmaceuticals Corp. and Director-Clinical Development at Glaxo Smith Kline Biologicals NA.

Dr. El-Hariry received a doctorate from Imperial College London and a doctorate from Alexandria Faculty of Medicine.